U.S. Marine and Shipping Stock News

NYSE:GDDY
NYSE:GDDYIT

A Look At GoDaddy (GDDY) Valuation As Profitability Holds Up Against Softer Guidance

GoDaddy stock underperforms despite solid profitability metrics GoDaddy (GDDY) has been under pressure, with the share price showing negative returns over the past year and past 3 months, even as the company reports multi billion dollar revenue and positive net income. See our latest analysis for GoDaddy. Recent trading has been weak, with a 30 day share price return of 7.04% and a 90 day share price return of 35.84%, which has pulled the 1 year total shareholder return down to 55.45%. The 3...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Uses Bitcoin To Cut Debt And Refocus On AI Expansion

MARA Holdings sold over 15,000 bitcoin for about US$1.1b to buy back US$1b of convertible notes. The transaction reduces potential dilution from convertibles and alters the company’s balance between bitcoin holdings and debt. This move comes as MARA pivots more toward AI infrastructure and data center expansion. MARA Holdings (NasdaqCM:MARA), recently trading at around US$8.28, has seen mixed share performance, with a 5.1% gain over the past 30 days, a 40.0% decline over the past year and...
NYSE:BMY
NYSE:BMYPharmaceuticals

Expanded Opdivo Use and New Camzyos Data Could Be A Game Changer For Bristol Myers Squibb (BMY)

In March 2026, Bristol Myers Squibb reported expanded approvals for Opdivo in classical Hodgkin lymphoma and unveiled new clinical and real-world data for Camzyos in obstructive hypertrophic cardiomyopathy, including the successful Phase 3 SCOUT-HCM trial in adolescents. Together, these updates reinforce Bristol Myers Squibb’s position in oncology and cardiovascular care by broadening Opdivo’s treatment reach and deepening the evidence base behind Camzyos across a range of real-world and...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

A Look At CrowdStrike (CRWD) Valuation After New AI Security Platform Launches And Partnerships

CrowdStrike Holdings (CRWD) has been busy, rolling out a series of AI focused security updates and partnerships with IBM and Intel that tighten integration across SOC automation, AI PCs, data protection, and agent based defenses. See our latest analysis for CrowdStrike Holdings. Despite the flurry of AI focused launches and partnerships, CrowdStrike’s recent share price moves have been mixed. The stock has delivered a 10.14% 1 month share price return alongside a 19.13% 3 month share price...
NYSE:MRK
NYSE:MRKPharmaceuticals

Is It Too Late To Consider Merck (MRK) After Recent 40% One Year Rally?

Wondering if Merck at around US$119 per share still offers value, or if most of the upside is already reflected in the price? This article walks through the key data points that matter for you. Merck’s share price sits near US$119.37, with returns of 4.3% over 7 days, a 3.6% decline over 30 days, 12.1% year to date and 40.4% over the past year. This raises fair questions about both growth potential and how risk is being priced in. Recent news coverage around Merck has focused on its position...
NYSE:MCO
NYSE:MCOCapital Markets

Moody's Weighs Easing Bank Capital Rules Against Credit Risk And Valuation

Regulators are preparing to ease bank capital requirements, reducing the amount of capital some banks may need to hold against their assets. Moody's has flagged these planned changes as credit negative, signaling concern about higher credit risk for financial institutions. The shift in regulatory stance could influence how Moody's assesses bank balance sheets and assigns credit ratings across the sector. Moody's, traded as NYSE:MCO, sits at the center of global credit assessment, so any...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Is Commerce Bancshares (CBSH) Now At An Interesting Price After Recent Share Pullback?

If you are wondering whether Commerce Bancshares at around US$48.54 is starting to look like value, or still has more room to fall or recover, this article will walk you through what the current price might be implying. The stock has gained 2.2% over the last 7 days, although it remains 7.1% lower over the past month and 17.1% lower over the last year. This may have some investors reassessing both its potential and its risks. Recent attention on the broader US banking sector, shifts in...
NYSE:DIS
NYSE:DISEntertainment

Disney Tech Setbacks Test New Leadership And Long Term Growth Story

Disney is confronting twin technology setbacks shortly after Josh D'Amaro became CEO. Epic Games, a key partner in Disney's planned digital universe, has announced major layoffs following weaker than expected user engagement. OpenAI has discontinued its Sora product, effectively ending Disney's AI content collaboration tied to that platform. These developments raise fresh questions about Disney's approach to digital partnerships, generative AI and long term tech investment plans. For...
NYSE:MET
NYSE:METInsurance

Is It Time To Reconsider MetLife (MET) After Recent Share Price Weakness?

If you are wondering whether MetLife's current share price reflects its underlying worth, the recent moves in the stock give you plenty to think about. The shares last closed at US$70.39, with a 2.6% gain over the past week, a 6.4% decline over 30 days, and returns of 12.4% decline year to date and 13.6% decline over the last year, set against gains of 36.7% and 34.8% over 3 and 5 years respectively. Recent headlines around MetLife have focused on the business as a large US insurer,...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence Elevates India R&D With Appointment Of Alok Jain As Managing Director

Cadence Design Systems (NasdaqGS:CDNS) has appointed Dr. Alok Jain as Managing Director for India. The appointment positions India as a key innovation and R&D hub for the company’s semiconductor and design software efforts. Dr. Jain is expected to focus on relationships across government, academia, and industry within India’s growing chip ecosystem. Cadence Design Systems, a major player in electronic design automation and semiconductor IP, is putting more executive weight behind India as a...
NYSE:CHE
NYSE:CHEHealthcare

Is It Time To Reassess Chemed (CHE) After Its Sharp Share Price Pullback?

If you are wondering whether Chemed at around US$374 per share still reflects its underlying worth, the current valuation picture offers some clear signals to work through. The share price has pulled back recently, with a 2.4% decline over the past week, a 21.8% drop over the last 30 days, and a 38.3% decline over the past year. This may have shifted how investors see both risk and potential reward. Recent coverage has focused on Chemed's role in healthcare services and how sector wide...
NYSE:KOF
NYSE:KOFBeverage

Should Coca-Cola FEMSA’s New Staggered 2026 Dividend Plan Reshape How KOF Investors View Its Capital Allocation?

At its March 24, 2025 AGM, Coca-Cola FEMSA, S.A.B. de C.V. approved a cash dividend of MXN 0.9675 per share (MXN 7.74 per KOF UBL unit) for fiscal 2025, to be paid in four equal installments during April, July, October, and December 2026. This multi‑installment dividend, spreading payments across the year, gives investors greater visibility on expected cash returns and may influence how they assess the company’s capital allocation and income profile. We’ll now examine how this AGM-approved,...
NYSE:PPG
NYSE:PPGChemicals

PPG Industries (PPG) Is Up 5.9% After Launching InsightsNav And Committing US$10M To Skilled Trades

Earlier this week, PPG Industries introduced PPG InsightsNav, a global analytics platform that helps marine customers standardize and analyze seastock coatings purchasing data, while also reaffirming a commitment to invest US$10.00 million through 2030 in skilled trades programs tied to advanced manufacturing and coatings applications. Together, the digital InsightsNav offering and long-term skilled trades funding highlight how PPG is pairing data-driven tools with workforce development to...
NYSE:LNG
NYSE:LNGOil and Gas

Is Cheniere Energy’s (LNG) New Long-Dated Bond Deal Rewriting Its Balance Sheet Strategy?

Earlier this month, Cheniere Energy closed a private offering of US$1.00 billion of 5.200% Senior Notes due 2036 and US$750.00 million of 6.000% Senior Notes due 2056, issued just below par under an indenture with The Bank of New York Mellon and carrying customary covenants and optional redemption features. The unregistered Rule 144A and Regulation S issuance adds long-dated, senior unsecured debt that Cheniere can later exchange into registered securities, potentially broadening its...
NYSE:HPQ
NYSE:HPQTech

HP NearSense And AI Security Push Put Focus Back On Valuation

HP (NYSE:HPQ) has introduced HP NearSense, a new cross-device experience built with Google and Qualcomm for secure workflows across HP PCs, Android devices, and multiple workspaces. The company is expanding its local AI layer, HP IQ, across devices to support on-device, context-aware productivity features. HP also announced TPM Guard hardware to counter advanced physical attacks on business PCs and quantum-resistant security for its printer portfolio. For investors tracking NYSE:HPQ, these...
NYSE:NET
NYSE:NETIT

Did Cloudflare's (NET) Deeper SentinelOne Tie-Up Quietly Redefine Its AI Security Ambitions?

Earlier this month, SentinelOne announced it is expanding its partnership with Cloudflare to feed Cloudflare’s Zero Trust and edge security telemetry directly into SentinelOne’s Singularity AI SIEM, creating a unified, AI-driven threat detection and response experience for joint enterprise customers. This deeper integration positions Cloudflare’s network and security data as a core ingredient in AI-powered security operations, potentially enhancing its relevance in the shift toward...
NYSE:SMG
NYSE:SMGChemicals

Will ScottsMiracle-Gro's (SMG) New Patio Garden Bundle Redefine Its Direct-to-Consumer Strategy?

On March 18, 2026, ScottsMiracle-Gro, Bonnie Plants and Gardenuity launched the Inspired to Gro Patio Garden Collection, bundling plant nutrients, rooted starter plants and guided digital support into a single patio-gardening product now sold on Amazon, Bonnieplants.com and Gardenuity.com. The collaboration stands out by pairing physical gardening inputs with Gardenuity’s personalized coaching and weather-based alerts, aiming to remove common barriers that keep new gardeners from starting...
NasdaqCM:OCGN
NasdaqCM:OCGNBiotechs

Assessing Ocugen (OCGN) Valuation After Recent Share Price Volatility And Long Term Momentum

Ocugen (OCGN) has attracted fresh attention after recent trading left the shares at US$1.95, against a market value of about US$648.8m. This has prompted investors to reassess how its pipeline and financials line up. See our latest analysis for Ocugen. Recent trading has been choppy, with a 1-day share price return of 1.56% set against a 7-day share price return decline of 14.85%. However, the 90-day share price return of 35.42% and 1-year total shareholder return of 163.87% point to momentum...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Is Moderna (MRNA) Attractive After A 73% Year To Date Share Price Jump?

Wondering if Moderna at US$53.54 is a bargain or a value trap? This article walks through what the numbers are really saying about the stock. The share price return sits at 2.2% over 7 days, 6.5% over 30 days, 73.5% year to date and 70.1% over the last year, alongside a 64.0% decline over 3 years and a 59.1% decline over 5 years. Recent headlines around Moderna have focused on its position in the pharmaceutical and biotech space and how investors are reassessing companies in this part of the...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Is New U.S. Conversion Push And Wyoming Expansion Altering The Investment Case For Uranium Energy (UEC)?

In March 2026, Uranium Energy Corp. reported state approvals and startup of three new header houses at Christensen Ranch in Wyoming, alongside an NRC docket for its planned U.S. uranium conversion facility, advancing both production capacity and licensing progress for refining and conversion. These steps move the company closer to its goal of becoming a fully vertically integrated American nuclear fuel supplier, potentially enhancing control over the domestic fuel chain and mitigating...
NYSE:PAY
NYSE:PAYDiversified Financial

Assessing Paymentus Holdings (PAY) Valuation After Mixed Momentum And Rich P/E Ratio

Event driven move in Paymentus Holdings (PAY) Paymentus Holdings (PAY) is back on investor radars after recent trading activity highlighted a mixed return profile, with gains over the past month set against a roughly 21% decline over the past 3 months. See our latest analysis for Paymentus Holdings. At a share price of US$25.10, Paymentus sits between a modest 30 day share price return and a much weaker 90 day share price return, while the 3 year total shareholder return above 100% points to...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix Backs Away From Warner Deal To Focus On Core Growth Choices

Netflix, ticker NasdaqGS:NFLX, has walked away from a proposed acquisition of Warner Bros. Discovery. The move reflects a choice to focus on internal execution and selective investments instead of a large media merger. This decision keeps attention on Netflix's core streaming business, advertising build out, and product roadmap. Investors are assessing what this means for Netflix's growth plans and position in the broader streaming market. Netflix runs a global streaming platform that...
NYSE:AN
NYSE:ANSpecialty Retail

AutoNation (AN) Valuation Check After Softer Quarterly Results And Recent Share Price Weakness

Investor activism meets softer quarterly results AutoNation (AN) is facing closer investor scrutiny after a softer Q4, with revenue down 3.9% year on year and earnings missing analyst estimates, even as After-Sales and Customer Financial Services reported record gross profit. See our latest analysis for AutoNation. AutoNation's share price has softened recently, with a 30 day share price return of 1.64% decline and a 90 day share price return of 8.82% decline, even as the 1 year total...
NYSE:ABBV
NYSE:ABBVBiotechs

Independent Chair Push Tests AbbVie Governance And Valuation Expectations

A shareholder group has filed a proposal for AbbVie to require an independent Chair of the Board. AbbVie’s board is urging investors to vote against the proposal at the 2026 annual general meeting. The proposal focuses on board independence, oversight, and how closely governance aligns with shareholder interests. For investors following AbbVie, NYSE:ABBV, this governance debate comes at a time when the stock trades around $207.18 and has seen a 6.4% return over the past year and 131.8% over...